This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://digital.ahrq.gov/contact-us. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to digital.ahrq.gov for current information.

A pharmacy intervention program: recognizing pharmacy's contribution to improving patient care

Authors
Chin JM, Muller RJ, Lucarelli CD
Journal
Hosp Pharm
Publication Date
1995
Volume
30
Issue
2
Pages
120, 123-6, 129-30
  • HIT Description: On-line pharmacy intervention program. More info...
  • Purpose of Study: Determine most common intervention types performed by pharmacists, and pharmacistsÕ contributions to patient care through an on-line pharmacy intervention program.
  • Years of study: 1992-1993
  • Study Design: Cross-sectional
  • Outcomes: Impact on health care effectivness/quality, Other outcome
Summary:
  • Settings: The study was conducted at the Memorial Sloan-Kettering Cancer Center, a 565 bed comprehensive cancer center in New York City.
  • Intervention: An on-line pharmacy intervention program with different types of interventions performed by a pharmacist.
  • Evaluation Method: Measures of the number and types of interventions and their impact on patient care collated and reviewed by a clinical coordinator over a 1-year period.
  • HIT System: o The center's pharmacy used the Shared Medical System, to which an on-line pharmacy intervention program was added, and it was accessed through any order entry menu
  • Quality of Care and Patient Safety Outcome: Two thousand four hundred ninety-nine interventions were recorded. The most common types of interventions were order clarification/change (18%), pharmacokinetic consult (16%), chart review (13%), restricted drug follow-up (8%), discharge medication screen (7%), initiate drug therapy (6%), drug information (5%), discontinued drug (4%), and therapeutic alternative (4%). There were 3459 impact codes assigned to these interventions. Forty-one percent decreased toxicity, 35% increased efficacy, 17% decreased cost, 16% avoided allergy or drug interaction, 8% improved compliance, and 22% were classified as other.
The information on this page is archived and provided for reference purposes only.